Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Abstract LB188: Discovery and development of fully human TACI/BCMA bispecific armored CAR for the treatment of relapsed/refractory multiple myeloma

Garima Agrahari, Wenle Liang, Katie O'Callaghan, Keming Zhang, Ning Jiang, Xiaoyi Jin, Ryan Feng, Jenna Nguyen, Sam Hassan, Annie Luu, Tony Ruan, Kehao Zhao, Yan Chen

Cancer Res (2023) 83 (8_Supplement): LB188.

https://doi.org/10.1158/1538-7445.AM2023-LB188

Published: 14 April 2023

View article titled, Abstract LB188: Discovery and development of fully human TACI/BCMA bispecific armored CAR for the treatment of relapsed/refractory multiple myeloma

Journal Articles

Abstract 4605: Efficient targeting of BCMA-positive multiple myeloma cells by antibody-coupled T-cell receptor (ACTR) engineered autologous T cells in combination with an anti-BCMA antibody

Tooba Cheema, Taylor Hickman, Katie O'Callaghan, Lori Westendorf, Luke Manlove, Shyra Gardai, Allison Nelson, Ryan Boomer, Kathleen McGinness, Birgit Schultes, Seth Ettenberg, Django Sussman, Heather Huet

Cancer Res (2017) 77 (13_Supplement): 4605.

https://doi.org/10.1158/1538-7445.AM2017-4605

Published: 01 July 2017

View article titled, Abstract 4605: Efficient targeting of BCMA-positive multiple myeloma cells by antibody-coupled T-cell receptor (ACTR) engineered autologous T cells in combination with an anti-BCMA antibody

Journal Articles

Abstract 75: Comparison of site-specific and lysine-linked indolino-benzodiazepine antibody-drug conjugates (ADCs)

Chen Bai, Nicholas C. Yoder, Alan Wilhelm, Sharlene Adams, Kathleen Whiteman, Jenny Lee, Katie O'Callaghan, Erin Maloney, Manami Shizuka, Yelena Kovtun, Thomas A. Keating

Cancer Res (2017) 77 (13_Supplement): 75.

https://doi.org/10.1158/1538-7445.AM2017-75

Published: 01 July 2017

View article titled, Abstract 75: Comparison of site-specific and lysine-linked indolino-benzodiazepine antibody-drug conjugates (ADCs)

Journal Articles

Abstract C18: A new IGF‐I‐regulated micronutrient carrier in cancer cells

Katie O'Callaghan, Veronica Ayllon, Jean O'Keeffe, Yanru Wang, Orla Cox, Gary Loughran, Michael Forgac, Rosemary O'Connor

Cancer Res (2009) 69 (23_Supplement): C18.

https://doi.org/10.1158/0008-5472.FBCR09-C18

Published: 28 October 2014

View article titled, Abstract C18: A new IGF‐I‐regulated micronutrient carrier in cancer cells

Journal Articles

Abstract 3433: Deciphering the mechanism of synergy between the Heat Shock Protein 90 inhibitor retaspimycin HCl and docetaxel in preclinical models of non-small cell lung cancer.

Katie O'Callaghan, Brenda C. O'Connell, Bonnie Tillotson, Mark Douglas, Howard Stern, Kip A. West, Janid A. Ali, Paul Changelian, Karen McGovern, Vito J. Palombella, Christian C. Fritz, Jeff L. Kutok

Cancer Res (2013) 73 (8_Supplement): 3433.

https://doi.org/10.1158/1538-7445.AM2013-3433

Published: 15 April 2013

View article titled, Abstract 3433: Deciphering the mechanism of synergy between the Heat Shock Protein 90 inhibitor retaspimycin HCl and docetaxel in preclinical models of non-small cell lung cancer.

Journal Articles

Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis

Eric Yang, Adrienne Boire, Anika Agarwal, Nga Nguyen, Katie O'Callaghan, Powen Tu, Athan Kuliopulos, Lidija Covic

Cancer Res (2009) 69 (15): 6223–6231.

https://doi.org/10.1158/0008-5472.CAN-09-0187

Published: 29 July 2009

View article titled, Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis

Includes: Supplementary data

NARROW

Abstract LB188: Discovery and development of fully human TACI/BCMA bispecific armored CAR for the treatment of relapsed/refractory multiple myeloma

Abstract 4605: Efficient targeting of BCMA-positive multiple myeloma cells by antibody-coupled T-cell receptor (ACTR) engineered autologous T cells in combination with an anti-BCMA antibody

Abstract 75: Comparison of site-specific and lysine-linked indolino-benzodiazepine antibody-drug conjugates (ADCs)

Abstract C18: A new IGF‐I‐regulated micronutrient carrier in cancer cells

Abstract 3433: Deciphering the mechanism of synergy between the Heat Shock Protein 90 inhibitor retaspimycin HCl and docetaxel in preclinical models of non-small cell lung cancer.

Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis

Email alerts

AACR Journals

Abstract LB188: Discovery and development of fully human TACI/BCMA bispecific armored CAR for the treatment of relapsed/refractory multiple myeloma

Abstract 4605: Efficient targeting of BCMA-positive multiple myeloma cells by antibody-coupled T-cell receptor (ACTR) engineered autologous T cells in combination with an anti-BCMA antibody

Abstract 75: Comparison of site-specific and lysine-linked indolino-benzodiazepine antibody-drug conjugates (ADCs)

Abstract C18: A new IGF‐I‐regulated micronutrient carrier in cancer cells

Abstract 3433: Deciphering the mechanism of synergy between the Heat Shock Protein 90 inhibitor retaspimycin HCl and docetaxel in preclinical models of non-small cell lung cancer.

Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only